| Overview |
| bs-2407R-Cy5 |
| SV2A Polyclonal Antibody, Cy5 Conjugated |
| FCM, IF(IHC-P) |
| Human |
| Mouse, Rat, Dog, Cow, Pig, Horse, Rabbit |
| Specifications |
| Cy5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human SV2A |
| 451-550/743 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 9900 |
| Q7L0J3 |
| Cytoplasm, Cell membrane |
| SV2; Synaptic vesicle glycoprotein 2A; SV2A; KIAA0736; PSEC0174 |
| Plays a role in the control of regulated secretion in neural and endocrine cells, enhancing selectively low-frequency neurotransmission. Positively regulates vesicle fusion by maintaining the readily releasable pool of secretory vesicles (By similarity). |
| Application Dilution |
| FCM |
1:20-100 |
| IF(IHC-P) |
1:50-200 |
Powered by Bioz